Clinical Trials Directory

Trials / Completed

CompletedNCT00439855

Enoxaparin Versus Unfractionated Heparin in PCI

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2,100 (planned)
Sponsor
Triemli Hospital · Academic / Other
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

Enoxaparin 0.75mg/kg BW is not inferior to weight adjusted unfractionated heparin as anticoagulation for PCI

Conditions

Interventions

TypeNameDescription
DRUGEnoxaparin i.v.
DRUGunfractionated heparin

Timeline

Start date
2003-09-01
Completion
2006-02-01
First posted
2007-02-26
Last updated
2007-02-26

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00439855. Inclusion in this directory is not an endorsement.

Enoxaparin Versus Unfractionated Heparin in PCI (NCT00439855) · Clinical Trials Directory